BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32725682)

  • 1. The efficacy of medical treatment for adenomyosis after adenomyomectomy.
    Li Q; Yuan M; Li N; Zhen Q; Chen C; Wang G
    J Obstet Gynaecol Res; 2020 Oct; 46(10):2092-2099. PubMed ID: 32725682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
    Sun F; Zhang Y; You M; Yang Y; Yu Y; Xu H
    J Obstet Gynaecol Res; 2021 Feb; 47(2):613-620. PubMed ID: 33174318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
    Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
    Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
    Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
    Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
    Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
    Li L; Leng J; Jia S; Lang J
    Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
    Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
    Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
    Zhang P; Song K; Li L; Yukuwa K; Kong B
    Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis.
    Jiang J; Pan Y; Yu J; Zhang Y; Yang Y; Xu H; Sun F
    BMC Womens Health; 2024 Jan; 24(1):28. PubMed ID: 38191409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
    Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
    Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
    Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
    J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
    Ye MZ; Deng XL; Zhu XG; Xue M
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
    Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
    Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
    Otgontuya A; Jeng CJ; Wu TN; Chuang LT; Shen J
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):226-238. PubMed ID: 36965889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
    Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.